CELLBOX | Innovative transport of “in culture” cell-based materials ensuring product safety, quality and function

Summary
In cooperation with Fraunhofer Institute, we developed an innovative technology for transporting live cell cultures, tissue and other cell-based samples - Cellbox. Cellbox is a self-sustaining incubator with a controlled environment, where temperature and CO2 can be adjusted to ensure optimal incubation conditions. With Cellbox, valuable cells are not lost due to freezing, thawing and recovering cells, thus reducing the risk of changing the biological structure of the cells and maintaining their high quality.

We currently have Cellbox 1.0 ready to go to market: Cellbox Ground for transports on the road and by rail and Cellbox Flight (IATA approved). A future version, Cellbox AT (Advanced Therapy), will fully unleash the potential of live cell transport for the cell therapy and regenerative medicine markets, where increasingly complex and sensitive biological materials are handled, transported and finally delivered to the patient (the scope of the EIC project).
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190197114
Start date: 01-10-2023
End date: 30-09-2025
Total budget - Public funding: 4 221 174,70 Euro - 2 500 000,00 Euro
Cordis data

Original description

In cooperation with Fraunhofer Institute, we developed an innovative technology for transporting live cell cultures, tissue and other cell-based samples - Cellbox. Cellbox is a self-sustaining incubator with a controlled environment, where temperature and CO2 can be adjusted to ensure optimal incubation conditions. With Cellbox, valuable cells are not lost due to freezing, thawing and recovering cells, thus reducing the risk of changing the biological structure of the cells and maintaining their high quality.

We currently have Cellbox 1.0 ready to go to market: Cellbox Ground for transports on the road and by rail and Cellbox Flight (IATA approved). A future version, Cellbox AT (Advanced Therapy), will fully unleash the potential of live cell transport for the cell therapy and regenerative medicine markets, where increasingly complex and sensitive biological materials are handled, transported and finally delivered to the patient (the scope of the EIC project).

Status

SIGNED

Call topic

HORIZON-EIC-2023-ACCELERATOROPEN-01

Update Date

12-03-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATOROPEN-01 EIC Accelerator Open 2023